The AI-driven drug discovery program uses not only artificial intelligence but also machine learning, which is a relatively new concept and is continuously expanding The use of artificial intelligence in the drug development space may help eliminate or reduce the manual operations that a company typically must undergo to identify and make necessary improvements to […]

Congressman Earl Blumenauer recently wrote to his peers, urging them to petition the DEA to permit terminally ill patients to use psilocybin as part of their treatment Although 41 states permit terminal patients to try investigational drugs, psilocybin continues to be banned by the DEA Change seems to be coming within the sector as evidenced […]

Bitcoin saw many different milestones during 2021, including surpassing $1 trillion in market value LQwD launched its PaaS, lqwd.tech, on November 17, amidst the Adopting Bitcoin – A Lightning Summit in El Salvador The Lightning Network has seen explosive growth since January 2021 LQwD’s corporate and operational update highlights several of the company’s achievements regarding […]

Bitcoin prices rose to an all-time high of $69K in 2021, spurring a tide of consumer interest in the cryptocurrency market BlockFi capitalized on this demand through the release of the first-ever crypto rewards credit card, signing up 75,000 clients in 2021 Improvements to its trading experience helped BlockFi expand its overall client base from […]

StraightUp has hired experienced commodities entrepreneur and economic geologist Rod Husband as its new CEO as it enters 2022 in an expansionist phase Mineral property exploration company StraightUp Resources is building excitement for several properties it has optioned in the gold-producing region of Ontario’s famed Red Lake Mining District StraightUp also acquired a mine in […]

CEO to participate in panel discussion, fireside chat focusing on psychedelics The company is engineering next-generation psychedelic molecules as it works to transform the mental health treatment landscape CYBN is implementing a three-pillar strategy Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing psychedelics to therapeutics, is gaining recognition as a leader in […]

Lexaria has received approval from the Independent Review Board for its DehydraTECH-CBD Human Clinical HYPER-H21-4 study The approval signals the company has taken the appropriate steps to protect the rights and welfare of human subjects participating in its fourth human study HYPER-H21-4 should “de-risk” outcomes prior to Lexaria’s planned entry into regulatory pathways for the […]

GreenBox POS reported $8 million in revenue for Q3 2021 on $540 million processed transaction volume GreenBox’s guidance for FY2022 forecasts processing volume of at least $4.9 billion The company’s planned spinoff of its coyni smart contract token technology is expected to accelerate revenue growth GreenBox shareholders will have an opportunity to benefit from dividends […]

2021 marked the year when Flora Growth held its IPO – the company’s common shares commenced trading on the Nasdaq Capital Market in May under the ticker symbol “FLGC” It also marked the year when the company ventured into the European market, as well as other key regions such as Mexico Significant acquisitions for the […]

Mydecine has signed a letter of intent with Maya detailing a collaborative partnership to develop a novel digital therapeutics (“DTx”) platform The DTx platform is expected to create a three-pronged approach to patient care by combining Mydecine’s Mindleap digital health platform with its medication-based treatments According to COO Damon Michaels, the new platform will provide […]